A citation-based method for searching scientific literature

David Chun Cheong Tsui, D Ross Camidge, Chad G Rusthoven. J Clin Oncol 2022
Times Cited: 5







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


First-Line Immunotherapy for Non-Small-Cell Lung Cancer.
Martin Reck, Jordi Remon, Matthew D Hellmann. J Clin Oncol 2022
23
40

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Thanyanan Reungwetwattana, Kazuhiko Nakagawa, Byoung Chul Cho, Manuel Cobo, Eun Kyung Cho, Alessandro Bertolini, Sabine Bohnet, Caicun Zhou, Ki Hyeong Lee, Naoyuki Nogami,[...]. J Clin Oncol 2018
311
40

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
David J H Shih, Naema Nayyar, Ivanna Bihun, Ibiayi Dagogo-Jack, Corey M Gill, Elisa Aquilanti, Mia Bertalan, Alexander Kaplan, Megan R D'Andrea, Ugonma Chukwueke,[...]. Nat Genet 2020
91
40

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
Paul W Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley, Xianghua Luo, Penny K Sneed, Samuel T Chao, Robert J Weil, John Suh,[...]. J Clin Oncol 2012
894
40

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs.
E Felip, A T Shaw, A Bearz, D R Camidge, B J Solomon, J R Bauman, T M Bauer, S Peters, F Toffalorio, A Abbattista,[...]. Ann Oncol 2021
25
40

Contraction of T cell richness in lung cancer brain metastases.
Aaron S Mansfield, Hongzheng Ren, Shari Sutor, Vivekananda Sarangi, Asha Nair, Jaime Davila, Laura R Elsbernd, Julia B Udell, Roxana S Dronca, Sean Park,[...]. Sci Rep 2018
53
40

Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain Metastases.
Fan Yu, Jianjiao Ni, Wanqin Zeng, Yue Zhou, Tiantian Guo, Ya Zeng, Yang Zhao, Shuyan Li, Yida Li, Xi Yang,[...]. Int J Radiat Oncol Biol Phys 2021
7
40

Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial.
Rudolf M Huber, Karin H Hansen, Luis Paz-Ares Rodríguez, Howard L West, Karen L Reckamp, Natasha B Leighl, Marcello Tiseo, Egbert F Smit, Dong-Wan Kim, Scott N Gettinger,[...]. J Thorac Oncol 2020
69
40

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, Amit Mahajan, Roy S Herbst, Anne C Chiang, Rogerio Lilenbaum, Frederick H Wilson, Sacit Bulent Omay, James B Yu,[...]. Lancet Oncol 2020
183
40

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial.
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, Daniel S W Tan, Dwight H Owen, Byoung Chul Cho, Herbert H Loong, Caroline E McCoach, Jared Weiss, Yu Jung Kim,[...]. Clin Cancer Res 2021
17
40


Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
Michael A Vogelbaum, Paul D Brown, Hans Messersmith, Priscilla K Brastianos, Stuart Burri, Dan Cahill, Ian F Dunn, Laurie E Gaspar, Na Tosha N Gatson, Vinai Gondi,[...]. J Clin Oncol 2022
29
40

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.
Shirish M Gadgeel, Leena Gandhi, Gregory J Riely, Alberto A Chiappori, Howard L West, Michele C Azada, Peter N Morcos, Ruey-Min Lee, Linta Garcia, Li Yu,[...]. Lancet Oncol 2014
502
40

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
Paul W Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal Aizer, Nancy U Lin, Eric Nesbit, Tim J Kruser, Jason Chan, Steve Braunstein,[...]. J Clin Oncol 2020
78
40

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, Hubert Pan, Paul D Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E Gaspar, Steve Braunstein,[...]. JAMA Oncol 2017
342
40

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
William J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, T Jonathan Yang, Natalie A Lockney, Naamit K Gerber, Kathryn Beal, Arya Amini, Tejas Patil, Brian D Kavanagh,[...]. J Clin Oncol 2017
254
40

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Paul Baas, Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto, Solange Peters, Anne S Tsao, Aaron S Mansfield, Sanjay Popat, Thierry Jahan, Scott Antonia,[...]. Lancet 2021
294
20


Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer.
Jeffrey A Bogart, Saiama N Waqar, Michael D Mix. J Clin Oncol 2022
4
25

New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.
Anne S Tsao, Harvey I Pass, Andreas Rimner, Aaron S Mansfield. J Clin Oncol 2022
3
33

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2018
20

Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies.
Antonio Passaro, Julie Brahmer, Scott Antonia, Tony Mok, Solange Peters. J Clin Oncol 2022
10
20

Systemic and Radiation Therapy Approaches for Locally Advanced Non-Small-Cell Lung Cancer.
Kristin A Higgins, Sonam Puri, Jhanelle E Gray. J Clin Oncol 2022
4
25

Patient-Centered Palliative Care for Patients With Advanced Lung Cancer.
Jennifer S Temel, Laura A Petrillo, Joseph A Greer. J Clin Oncol 2022
2
50

Practical Management of Oligometastatic Non-Small-Cell Lung Cancer.
Katie Jasper, Brendon Stiles, Fiona McDonald, David A Palma. J Clin Oncol 2022
4
25

Surgical Issues for Operable Early-Stage Non-Small-Cell Lung Cancer.
Jessica Donington, Lana Schumacher, Jane Yanagawa. J Clin Oncol 2022
2
50


Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Enriqueta Felip, Nasser Altorki, Caicun Zhou, Tibor Csőszi, Ihor Vynnychenko, Oleksandr Goloborodko, Alexander Luft, Andrey Akopov, Alex Martinez-Marti, Hirotsugu Kenmotsu,[...]. Lancet 2021
139
20

Indications and Parameters Around Postoperative Radiation Therapy for Lung Cancer.
Antonin Levy, Olaf Mercier, Cécile Le Péchoux. J Clin Oncol 2022
3
33

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Konstantin Laktionov, Sang-We Kim, Terufumi Kato,[...]. N Engl J Med 2020
451
20


Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
Zhouguang Hui, Yu Men, Chen Hu, Jingjing Kang, Xin Sun, Nan Bi, Zongmei Zhou, Jun Liang, Jima Lv, Qinfu Feng,[...]. JAMA Oncol 2021
36
20


The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer. N Engl J Med 2020
383
20

Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.
Jamie E Chaft, Yu Shyr, Boris Sepesi, Patrick M Forde. J Clin Oncol 2022
17
20

Frequent EGFR mutations in brain metastases of lung adenocarcinoma.
Shingo Matsumoto, Kenji Takahashi, Reika Iwakawa, Yoshihiro Matsuno, Yukihiro Nakanishi, Takashi Kohno, Eiji Shimizu, Jun Yokota. Int J Cancer 2006
149
20


Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee,[...]. J Clin Oncol 2021
99
20

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Giuseppe Minniti, Dimitri Anzellini, Chiara Reverberi, Gian Carlo Antonini Cappellini, Luca Marchetti, Federico Bianciardi, Alessandro Bozzao, Mattia Osti, Pier Carlo Gentile, Vincenzo Esposito. J Immunother Cancer 2019
66
20

Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
Jin-Ji Yang, Caicun Zhou, Yisheng Huang, Jifeng Feng, Sun Lu, Yong Song, Cheng Huang, Gang Wu, Li Zhang, Ying Cheng,[...]. Lancet Respir Med 2017
115
20

"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.
Christian Grommes, Geoffrey R Oxnard, Mark G Kris, Vincent A Miller, William Pao, Andrei I Holodny, Jennifer L Clarke, Andrew B Lassman. Neuro Oncol 2011
249
20

The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.
Joseph M Kim, Jacob A Miller, Rupesh Kotecha, Roy Xiao, Aditya Juloori, Matthew C Ward, Manmeet S Ahluwalia, Alireza M Mohammadi, David M Peereboom, Erin S Murphy,[...]. J Neurooncol 2017
62
20

Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
Franziska Maria Ippen, Julia Katharina Grosch, Megha Subramanian, Benjamin Macfarlane Kuter, Bianca M Liederer, Emile G Plise, Joana Liliana Mora, Naema Nayyar, Stephen Paul Schmidt, Anita Giobbie-Hurder,[...]. Neuro Oncol 2019
46
20

Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
Valerio Leoni, Valentina Gatta, Arianna Palladini, Giordano Nicoletti, Dario Ranieri, Massimiliano Dall'Ora, Valentina Grosso, Martina Rossi, Francesco Alviano, Laura Bonsi,[...]. Oncotarget 2015
46
20

Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.
Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Jumpei Takeshita, Kosuke Tanaka, Shigeki Nanjo, Shiro Fujita, Reiko Kaji, Yukihiro Imai, Kazuya Monden,[...]. Cancer 2013
152
20



Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma.
Lisa Haas, Anais Elewaut, Camille L Gerard, Christian Umkehrer, Lukas Leiendecker, Malin Pedersen, Izabela Krecioch, David Hoffmann, Maria Novatchkova, Mario Kuttke,[...]. Nat Cancer 2021
27
20

Breast cancer metastasis to the central nervous system.
Robert J Weil, Diane C Palmieri, Julie L Bronder, Andreas M Stark, Patricia S Steeg. Am J Pathol 2005
309
20

Epidemiology and prognosis of brain metastases.
Keith J Stelzer. Surg Neurol Int 2013
103
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.